{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:52:06Z","timestamp":1783039926847,"version":"3.54.6"},"reference-count":49,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Heparin-induced thrombocytopenia (HIT) is characterized by the production of pathogenic antibodies that bind to complexes of platelet factor 4 (PF4) and heparin, causing platelet activation and a hypercoagulable state. A significant proportion of heparin-treated patients develop nonpathogenic anti-PF4\/heparin antibodies that do not activate platelets but interfere with routine screening tests causing frequent false-positive results. We recently showed that pathogenic HIT antibodies are monoclonal and bind to an overlapping PF4 binding site, which could be exploited to identify clinically significant antibodies in patients. This study aimed to develop epitope-specific inhibitors based on the HIT-like murine monoclonal antibody (KKO) that recognizes a binding site overlapping with patient-derived pathogenic HIT antibodies on PF4. We developed a wild-type single-chain variable fragment (scFv) derived from KKO and performed site-directed mutagenesis to create a library of mutant anti-PF4\/heparin scFv sequences. Five candidate scFvs were selected based on sequence enrichment after phage biopanning. We confirmed the high affinity and specific binding of these scFv fragments to PF4\/heparin complexes using enzyme immunoassays (EIAs) and biolayer interferometry and demonstrated that KKO and all scFvs bind to an overlapping heparin-dependent site on PF4 by epitope mapping. Using patient sera, we demonstrated that our scFv candidates selectively inhibit the binding of pathogenic anti-PF4\/heparin HIT antibodies and prevented platelet activation of some samples in the serotonin release assay. Importantly, the binding of nonpathogenic antibodies to PF4\/heparin was unperturbed. These findings support the use of scFvs targeting a shared pathogenic region on PF4 to improve the diagnostic accuracy of anti-PF4\/heparin EIAs for HIT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031696","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:55:03Z","timestamp":1778165703000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Engineering single-chain variable fragments to identify pathogenic antibodies in heparin-induced thrombocytopenia"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-8473","authenticated-orcid":false,"given":"Anna-Lise","family":"Bissola","sequence":"first","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0943-8853","authenticated-orcid":false,"given":"Donald M.","family":"Arnold","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2552-746X","authenticated-orcid":false,"given":"Mark","family":"Lychacz","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Sparring","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"3Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7149-2781","authenticated-orcid":false,"given":"Mercy","family":"Daka","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6416-2453","authenticated-orcid":false,"given":"Jared","family":"Treverton","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"},{"name":"4Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Clare","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-2383","authenticated-orcid":false,"given":"John G.","family":"Kelton","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-7603","authenticated-orcid":false,"given":"Colin A.","family":"Kretz","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"3Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada"},{"name":"4Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-4343","authenticated-orcid":false,"given":"Ishac","family":"Nazy","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada"},{"name":"2Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada"},{"name":"4Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2026070211210918000_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"issue":"5","key":"2026070211210918000_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"issue":"10","key":"2026070211210918000_bib3","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2026070211210918000_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2026070211210918000_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09537109975960","article-title":"Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG\/serum and other IgG platelet agonists: a comparison with standard platelet agonists","volume":"10","author":"Warkentin","year":"1999","journal-title":"Platelets"},{"issue":"11","key":"2026070211210918000_bib6","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"issue":"2","key":"2026070211210918000_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jth.12098","article-title":"Anti-PF4\/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis","volume":"11","author":"Warkentin","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026070211210918000_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00001721-200110000-00002","article-title":"The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia","volume":"12","author":"Gerotziafas","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"2026070211210918000_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jca.20109","article-title":"Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly\/disassembly","volume":"22","author":"Cines","year":"2007","journal-title":"J Clin Apher"},{"key":"2026070211210918000_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2141.1998.00750.x","article-title":"High incidence of anti-heparin\/platelet factor 4 antibodies after cardiopulmonary bypass surgery","volume":"101(4)","author":"Trossaert","year":"1998","journal-title":"Br J Haematol"},{"issue":"3","key":"2026070211210918000_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1538-7836.2007.02870.x","article-title":"Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass","volume":"6","author":"Selleng","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026070211210918000_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1651670","article-title":"Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases","volume":"73","author":"Amiral","year":"1995","journal-title":"Thromb Haemost"},{"key":"2026070211210918000_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-2143(96)80009-6","article-title":"Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes","volume":"128","author":"Visentin","year":"1996","journal-title":"J Lab Clin Med"},{"issue":"7","key":"2026070211210918000_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ajh.24025","article-title":"Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: a 6-year experience from a reference laboratory","volume":"90","author":"Nazi","year":"2015","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"2026070211210918000_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"41","author":"Warkentin","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"12","key":"2026070211210918000_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ajh.21032","article-title":"What is the potential for overdiagnosis of heparin-induced thrombocytopenia?","volume":"82","author":"Lo","year":"2007","journal-title":"Am J Hematol"},{"issue":"8","key":"2026070211210918000_bib17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays","volume":"6","author":"Warkentin","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026070211210918000_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"issue":"6","key":"2026070211210918000_bib19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"issue":"3","key":"2026070211210918000_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.chest.2016.02.641","article-title":"A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis","volume":"150","author":"Padmanabhan","year":"2016","journal-title":"Chest"},{"issue":"2","key":"2026070211210918000_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V89.2.370","article-title":"Fc gamma RIIA H\/R 131 polymorphism, subclass-specific IgG anti-heparin\/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis","volume":"89","author":"Arepally","year":"1997","journal-title":"Blood"},{"issue":"8","key":"2026070211210918000_bib22","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","article-title":"Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4\/heparin antibodies of the IgG, IgM, and IgA classes","volume":"5","author":"Greinacher","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026070211210918000_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jth.14369","article-title":"Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia","volume":"17","author":"Huynh","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2026070211210918000_bib24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMoa2507175","article-title":"Monoclonal antibodies in the pathogenesis of heparin-induced thrombocytopenia","volume":"393","author":"Treverton","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"2026070211210918000_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.V95.5.1533.005k01_1533_1540","article-title":"Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies","volume":"95","author":"Arepally","year":"2000","journal-title":"Blood"},{"key":"2026070211210918000_bib26","author":"Barbas","year":"2001"},{"key":"2026070211210918000_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4939-6863-3_11","article-title":"Mapping the substrate recognition landscapes of metalloproteases using comprehensive mutagenesis","volume":"1579","author":"Kretz","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2026070211210918000_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09537104.2017.1378808","article-title":"Development of a high-yield expression and purification system for platelet factor 4","volume":"29","author":"Huynh","year":"2018","journal-title":"Platelets"},{"issue":"7873","key":"2026070211210918000_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"2026070211210918000_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.thromres.2020.06.012","article-title":"The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia","volume":"194","author":"Huynh","year":"2020","journal-title":"Thromb Res"},{"issue":"10","key":"2026070211210918000_bib31","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jth.13066","article-title":"Distinguishing between anti-platelet factor 4\/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia","volume":"13","author":"Nazi","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2026070211210918000_bib32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"issue":"1","key":"2026070211210918000_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4049\/jimmunol.177.1.333","article-title":"Trends in antibody sequence changes during the somatic hypermutation process","volume":"177","author":"Clark","year":"2006","journal-title":"J Immunol"},{"key":"2026070211210918000_bib34","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"2026070211210918000_bib35","first-page":"993","article-title":"Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis","volume":"106","author":"Cuker","year":"2011","journal-title":"Thromb Haemost"},{"issue":"3","key":"2026070211210918000_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.thromres.2011.05.003","article-title":"Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4\/heparin enzyme-immunoassay","volume":"128","author":"Althaus","year":"2011","journal-title":"Thromb Res"},{"issue":"18","key":"2026070211210918000_bib37","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2013-01-479576","article-title":"Novel diagnostic assays for heparin-induced thrombocytopenia","volume":"121","author":"Cuker","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2026070211210918000_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jmr.2158","article-title":"Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens","volume":"25","author":"Raghunathan","year":"2012","journal-title":"J Mol Recognit"},{"issue":"14","key":"2026070211210918000_bib39","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1073\/pnas.1818744116","article-title":"Networks of electrostatic and hydrophobic interactions modulate the complex folding free energy surface of a designed betaalpha protein","volume":"116","author":"Basak","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026070211210918000_bib40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0952-7915(95)80010-7","article-title":"Somatic hypermutation","volume":"7","author":"Neuberger","year":"1995","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2026070211210918000_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1074\/jbc.M409783200","article-title":"In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin","volume":"280","author":"Ho","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"2026070211210918000_bib42","first-page":"995","article-title":"Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display","volume":"8","author":"Salvatore","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2026070211210918000_bib43","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jtha.2024.05.005","article-title":"The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"22","author":"Vayne","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2026070211210918000_bib44","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood.2022017612","article-title":"Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis","volume":"141","author":"Zhu","year":"2023","journal-title":"Blood"},{"issue":"26","key":"2026070211210918000_bib45","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.2023022136","article-title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","volume":"142","author":"Schonborn","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2026070211210918000_bib46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"Warkentin","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"2026070211210918000_bib47","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2022","journal-title":"Haematologica"},{"issue":"14","key":"2026070211210918000_bib48","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood.2022018797","article-title":"Monoclonal gammopathy of thrombotic\/thrombocytopenic significance","volume":"141","author":"Kanack","year":"2023","journal-title":"Blood"},{"issue":"10","key":"2026070211210918000_bib49","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa2415930","article-title":"VITT-like monoclonal gammopathy of thrombotic significance","volume":"392","author":"Wang","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/103\/2531348\/blood_bld-2025-031696-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/103\/2531348\/blood_bld-2025-031696-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:21:45Z","timestamp":1783005705000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/1\/103\/567584\/Engineering-single-chain-variable-fragments-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031696","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,2]]},"published":{"date-parts":[[2026,7,2]]}}}